Roundhill NVDA WeeklyPay ETF vs 22nd Century Group Inc — how do they compare? Roundhill NVDA WeeklyPay ETF trades at $35.85, while 22nd Century Group Inc trades at $4.48 (market cap $1.49M). Which is the better fit depends on your goals.
| NVDW | XXII | |
|---|---|---|
Sector | Income / Options Overlay | Technology |
52-Week High | $53.42 | $1.07K |
52-Week Low | $31.88 | $3.90 |
Market Cap | — | $1.49M |
Enterprise Value | — | -$6.74M |
Signals from Pluang's Aura AI — not financial advice
NVDW trades at $35.2, down 1.1% for the day, with a strong bearish technical signal from moving averages. The stock exhibits a high-dividend profile with frequent payouts, though the yield is variable. Recent coverage highlights its role as a quasi-synthetic leveraged play on Nvidia, offering significant income generation potential.
The outlook is mixed, balancing a high-yield income stream against technical weakness and dependency on Nvidia's performance. Key risks include payout volatility and concentrated exposure. The investment case hinges on income generation amid a bearish trend.
XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.
The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.
Trailing returns across standard periods
NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →